BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29967951)

  • 1. Development and characterization of an inducible mouse model for glycogen storage disease type Ib.
    Raggi F; Pissavino AL; Resaz R; Segalerba D; Puglisi A; Vanni C; Antonini F; Del Zotto G; Gamberucci A; Marcolongo P; Bosco MC; Grillo F; Mastracci L; Eva A
    J Inherit Metab Dis; 2018 Nov; 41(6):1015-1025. PubMed ID: 29967951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter.
    Chen LY; Shieh JJ; Lin B; Pan CJ; Gao JL; Murphy PM; Roe TF; Moses S; Ward JM; Lee EJ; Westphal H; Mansfield BC; Chou JY
    Hum Mol Genet; 2003 Oct; 12(19):2547-58. PubMed ID: 12925567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.
    Chou JY; Jun HS; Mansfield BC
    J Inherit Metab Dis; 2015 May; 38(3):511-9. PubMed ID: 25288127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology and gene therapy for glycogen storage disease type Ib.
    Chou JY; Cho JH; Kim GY; Mansfield BC
    J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration.
    Kim GY; Lee YM; Kwon JH; Jun HS; Chou J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):569-574. PubMed ID: 27864142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
    Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
    FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
    Chen LY; Pan CJ; Shieh JJ; Chou JY
    Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-directed gene therapy for murine glycogen storage disease type Ib.
    Kwon JH; Lee YM; Cho JH; Kim GY; Anduaga J; Starost MF; Mansfield BC; Chou JY
    Hum Mol Genet; 2017 Nov; 26(22):4395-4405. PubMed ID: 28973635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SLC37 family of phosphate-linked sugar phosphate antiporters.
    Chou JY; Sik Jun H; Mansfield BC
    Mol Aspects Med; 2013; 34(2-3):601-11. PubMed ID: 23506893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib.
    Jun HS; Weinstein DA; Lee YM; Mansfield BC; Chou JY
    Blood; 2014 May; 123(18):2843-53. PubMed ID: 24565827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.
    Yiu WH; Pan CJ; Allamarvdasht M; Kim SY; Chou JY
    Gene Ther; 2007 Feb; 14(3):219-26. PubMed ID: 17006547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutropenia in type Ib glycogen storage disease.
    Chou JY; Jun HS; Mansfield BC
    Curr Opin Hematol; 2010 Jan; 17(1):36-42. PubMed ID: 19741523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib.
    Sim SW; Jang Y; Park TS; Park BC; Lee YM; Jun HS
    Cell Mol Life Sci; 2022 Apr; 79(5):246. PubMed ID: 35437689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy.
    Lee YM; Jun HS; Pan CJ; Lin SR; Wilson LH; Mansfield BC; Chou JY
    Hepatology; 2012 Nov; 56(5):1719-29. PubMed ID: 22422504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant proliferation and differentiation of glycogen storage disease type Ib mesenchymal stem cells.
    Sim SW; Park TS; Kim SJ; Park BC; Weinstein DA; Lee YM; Jun HS
    FEBS Lett; 2018 Jan; 592(2):162-171. PubMed ID: 29238966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-6-phosphate transporter mediates macrophage proliferation and functions by regulating glycolysis and mitochondrial respiration.
    Jeon EH; Park TS; Jang Y; Hwang E; Kim SJ; Song KD; Weinstein DA; Lee YM; Park BC; Jun HS
    Biochem Biophys Res Commun; 2020 Mar; 524(1):89-95. PubMed ID: 31980167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.
    Yiu WH; Pan CJ; Mead PA; Starost MF; Mansfield BC; Chou JY
    J Hepatol; 2009 Nov; 51(5):909-17. PubMed ID: 19376605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen storage disease type Ib: role of glucose-6-phosphate transporter in cell metabolism and function.
    Sim SW; Weinstein DA; Lee YM; Jun HS
    FEBS Lett; 2020 Jan; 594(1):3-18. PubMed ID: 31705665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids activate transcription of the gene for the glucose-6-phosphate transporter, deficient in glycogen storage disease type 1b.
    Hiraiwa H; Chou JY
    DNA Cell Biol; 2001 Aug; 20(8):447-53. PubMed ID: 11560776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant glucose metabolism underlies impaired macrophage differentiation in glycogen storage disease type Ib.
    Jang Y; Park TS; Park BC; Lee YM; Heo TH; Jun HS
    FASEB J; 2023 Nov; 37(11):e23216. PubMed ID: 37779422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.